Medifast Inc (MED)
Business numbers score is below the middle — price trend is one of its highest-scoring factors, while smart-money score is above the middle.
MED scores higher than 86% of the 653 tickers we compare it with (Consumer Discretionary).
As of 9 October 2026, Medifast Inc (MED) scores 57 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.52× 30-day average
- 52-week range
- 9.22 – 14.15
- Market cap
- $131.60M
- Earnings date
- 2 Nov 2026
- Volume
- 58,423
- Avg. volume (30d)
- 111,935
- Open
- 11.51
- Previous close
- 11.43
- Day's range (regular session)
- 11.42 – 11.64
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for MED
- 10 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for MED. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about MED right now
Medifast Inc (MED) currently scores 57/100 on the Market Census six-factor composite, at the Above average score level. MED is +1.57% on the day and -0.98% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for MED leans good, with some weak spots. MED's strongest factor is price trend at 80/100 — a very strong read on which way the price has been going. The weakest factor is company finances at 15/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See MED in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent MED news
Latest headlines that name Medifast, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Can Medifast's Better Client Retention Support Revenue Stabilization?Zacks Investment Research
- Q2 Earnings Roundup: Medifast (NYSE:MED) And The Rest Of The Personal Care SegmentYahoo
- Is Laird Superfood (LSF) Stock Outpacing Its Consumer Staples Peers This Year?Yahoo
- Why Is Medifast (MED) Down 7.6% Since Last Earnings Report?Zacks Investment Research
- Medifast: Worth A Speculative Entry As Sales Stabilize (Rating Upgrade)SeekingAlpha
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Consumer Discretionary right now
Six consumer discretionary tickers whose composite scores are closest to MED’s 57, all within 1 point.
Sorted by closeness to MED’s composite score within Consumer Discretionary. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.